Menin Reset

A study published October 12, 2026 found that Menin — a transcriptional scaffold encoded by MEN1 — progressively declines with age, destabilizing the KMT2A/MLL1 complex and disrupting Wnt, TGF-β, and IGF-1 signaling in stem cells. Restoring Menin in 22-month-old mice reversed gut regeneration failure, sarcopenia, and glucose intolerance. Toggle the switch to watch 32 cells age and rejuvenate.

Menin low. Without Menin the KMT2A/MLL1 complex loses its scaffold. Wnt target genes go dark; TGF-β drives cells into senescence; IGF-1 signaling turns pro-inflammatory rather than anabolic. Lipofuscin granules (amber dots) accumulate in the cytoplasm, nuclei deform and shift off-center, and membranes dim to rust orange — the classical markers of the aged, post-mitotic state.
Why Menin?

Menin was first characterized as the product of the MEN1tumor suppressor gene — its loss causes multiple endocrine neoplasia type 1. For decades it was studied as a cancer gene. The 2026 aging study reframed it: Menin's normal job is to scaffold the KMT2A/MLL1 histone methyltransferase complex onto chromatin, writing activating H3K4me3 marks at promoters required for stem cell self-renewal and metabolic homeostasis.

As Menin falls in aged tissue, the transcription factor FOXA2 loses access to its target promoters. Wnt ligand production drops; the intestinal crypt niche can no longer support ISC proliferation; muscle satellite cells fail to activate after micro-injury. The key finding: restoring Menin via an MLLT3-targeting agonist in 22-month-old mice (≈ 65-year-old human) reversed all three hallmarks — gut regeneration, muscle mass, glucose tolerance — within weeks, with no observed tumor formation.

Protein
Menin (MEN1 gene)
Complex
KMT2A/MLL1
Key mark
H3K4me3 (active)
Pathways
Wnt · TGF-β · IGF-1
Model organism
C57BL/6 mice
Mouse age
22 months (~65y human)
Reversal scope
Gut · muscle · glucose
Published
Oct 12, 2026
Menin aging pathway · restoration pipeline